Clinical Trial Update: TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer [NA]

View source ↗

Summary

Clinical trial update on TOBI to monitor response to neoadjuvant therapy in breast cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TOBI (Tobramycin inhalation solution)

Snippet

Sponsor: Steven Isakoff, MD, PhD | Conditions: Breast Cancer | NA | Status: COMPLETED